The Innovative Medicines Initiative has now launched IMI2 – Call 14. The Call has the following topics:
Targeted immune intervention for the management of non-response and relapse
Non-invasive clinical molecular imaging of immune cells
Development of a platform for federated and privacy-preserving machine learning in support of drug discovery
Centre of excellence – remote decentralised clinical trials
Deadline for submitting short proposals is 14th of June 2018.
You can use the euMatch Partner search tool to find potential partners
Find our more on the IMI2 Call 14 Website